Literature DB >> 21361876

TFCP2c/LSF/LBP-1c is required for Snail1-induced fibronectin gene expression.

Montserrat Porta-de-la-Riva1, Jelena Stanisavljevic, Josue Curto, Clara Francí, Víctor Manuel Díaz, Antonio García de Herreros, Josep Baulida.   

Abstract

Fibronectins are cell-secreted glycoproteins that modulate cell attachment, spreading, migration, morphology, differentiation and oncogenic transformation. Fibronectin expression is activated during EMT (epithelial-mesenchymal transition) and is a hallmark of mesenchymal cells. It is shown in the present study that a transcription factor previously unrelated with EMT, TFCP2c/LSF/LBP-1c, was translocated to the nucleus and bound to the fibronectin promoter upon EMT induction by Snail1. Consequently, the interference of TFCP2c/LSF/LBP-1c's activity prevented fibronectin expression. Moreover, TFCP2c/LSF/LBP-1c was detected in nuclei of embryonic dermal mesenchymal cells adjacent to the hair bud, a cell population that expresses endogenous nuclear Snail1 and fibronectin. Therefore we indicate a new molecular role for TFCP2c/LSF/LBP-1c in fibronectin expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361876     DOI: 10.1042/BJ20102057

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  Epithelial-mesenchymal transition in cervical carcinoma.

Authors:  Mei-Yi Lee; Meng-Ru Shen
Journal:  Am J Transl Res       Date:  2012-01-01       Impact factor: 4.060

2.  FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.

Authors:  Ioannis G Koutlas; Damon R Olson; Jawhar Rawwas
Journal:  Head Neck Pathol       Date:  2020-06-05

3.  WNT1-inducible signaling pathway protein 1 contributes to ventilator-induced lung injury.

Authors:  Hui-Hua Li; Quan Li; Pengyuan Liu; Yulin Liu; Jin Li; Karla Wasserloos; Wei Chao; Ming You; Tim D Oury; Sodhi Chhinder; David J Hackam; Timothy R Billiar; George D Leikauf; Bruce R Pitt; Li-Ming Zhang
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-14       Impact factor: 6.914

4.  The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

Authors:  Prasanna K Santhekadur; Devaraja Rajasekaran; Ayesha Siddiq; Rachel Gredler; Dong Chen; Scott E Schaus; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

5.  GP5 regulates epithelial-mesenchymal transition in breast cancer via the PI3K/AKT signaling pathway.

Authors:  Kui Xiang; Hua Yanshan; Zhao Chunmei; Guo Minmin; Wang Yan; Yi Xiaojia
Journal:  Exp Biol Med (Maywood)       Date:  2022-07-26

6.  Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.

Authors:  Xiao Xu; Zhikun Liu; Lin Zhou; Haiyang Xie; Jun Cheng; Qi Ling; Jianguo Wang; Haijun Guo; Xuyong Wei; Shusen Zheng
Journal:  J Exp Clin Cancer Res       Date:  2015-01-22

7.  Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.

Authors:  Devaraja Rajasekaran; Ayesha Siddiq; Jennifer L S Willoughby; Jessica M Biagi; Lisa M Christadore; Sarah A Yunes; Rachel Gredler; Nidhi Jariwala; Chadia L Robertson; Maaged A Akiel; Xue-Ning Shen; Mark A Subler; Jolene J Windle; Scott E Schaus; Paul B Fisher; Ulla Hansen; Devanand Sarkar
Journal:  Oncotarget       Date:  2015-09-22

Review 8.  Epithelial-mesenchymal transition in tumor metastasis.

Authors:  Kay T Yeung; Jing Yang
Journal:  Mol Oncol       Date:  2016-12-09       Impact factor: 6.603

Review 9.  Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review).

Authors:  Henrieta Škovierová; Terézia Okajčeková; Ján Strnádel; Eva Vidomanová; Erika Halašová
Journal:  Int J Mol Med       Date:  2017-12-13       Impact factor: 4.101

Review 10.  Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.

Authors:  Billy Samuel Hill; Alessandra Pelagalli; Nunzia Passaro; Antonella Zannetti
Journal:  Oncotarget       Date:  2017-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.